Exhibit 99.1

# NEWS RELEASE

---

FOR 3:00 P.M. CT RELEASE

January 25, 2006


|Contact:                |                              
|----------------------- | -----------------------------
|Sam Reinkensmeyer       | Shawn Brumbaugh/Marian Briggs
|Chief Financial Officer | Padilla Speer Beardsley Inc. 
|CNS, Inc.               | (612) 455-1700               
|(952) 229-1500          | sbrumbaugh@psbpr.com         
|sreinkensmeyer@cns.com  | mbriggs@psbpr.com            
|Nasdaq Symbol: CNXS    

CNS, Inc. Reports Fiscal 2006 Third Quarter Results

| |  | Third quarter net sales of $30.9 million rose 8 percent driven by strong Breathe
Right® international and FiberChoice® growth
| | - | -----------------------------------------------------------------------------------------------------------------------------

| |  | Third quarter operating income of $5.9 million grew 10 percent, excluding a prior year
benefit related to a refund of European import duties
| | - | --------------------------------------------------------------------------------------------------------------------------------------------

| |  | Company continues to estimate $1.05 to $1.12 fully diluted earnings per share for full year fiscal 2006
| | - | -------------------------------------------------------------------------------------------------------

MINNEAPOLIS,
January 25  CNS, Inc. (Nasdaq: CNXS), the Breathe Right® company,
today announced results for its fiscal 2006 third quarter ended December 31, 2005.

Net
sales for the quarter were $30.9 million, up 8 percent from $28.7 million in the prior
year period. Net income for the quarter ended December 31, 2005, totaled $4.0 million, or
$0.26 per fully diluted share. Net income for the prior year quarter was $4.4 million, or
$0.30 per fully diluted share, which included the benefit related to a duty refund of
$0.05 per fully diluted share.

For
the first nine months of fiscal 2006, CNS reported net sales of $80.5 million, up 23
percent compared to $65.3 million in the same period last year. Net income for the first
nine months of fiscal 2006 was $12.5 million, or $0.83 per share, compared to $9.6
million, or $0.65 per fully diluted share for the first nine months of fiscal 2005.
Excluding the non-recurring European import duty refund, fully diluted earnings per share
for the first nine months of fiscal 2006 grew 37 percent compared to the prior year.

Overall,
revenue growth in the third quarter moderated as anticipated, compared to last years
high sales volumes that resulted from the successful relaunch of domestic Breathe Right
clear strips, said Marti Morfitt, CNS president and CEO. During the
third quarter, we saw continued strong revenue growth in our Breathe Right international
and FiberChoice product lines. Our domestic Breathe Right sales were slightly below
expectations as our promotions were not as effective as planned. However, we expect
domestic Breathe Right revenues to return to growth in the fourth quarter.

---

CNS, Inc. Reports Fiscal 2006 Third Quarter Results
Page 2

CNS
continues to focus on a number of key initiatives to grow the Breathe Right and
FiberChoice brands including:

| |  | Growing nasal strip sales with tested, proven marketing tactics, including an effective
How it Works advertising demonstration to attract new nasal strip users;
| | - | ------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | Increasing FiberChoice sales with the expansion of advertising and the introduction of two
new FiberChoice products which will begin shipping in February 2006  FiberChoice
with CalciumTM and FiberChoice Weight ManagementTM;
| | - | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | Conducting market testing designed to create a robust pipeline of growth tactics for
Breathe Right nasal strips, both domestically and internationally; and
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | Building a pipeline of potential
new products for both the Breathe Right and FiberChoice brands.
| | - | ------------------------------------------------------------------------------------------------

On
January 5, 2006, CNS announced the purchase, from Onesta Nutrition, Inc., of a portfolio
of domestic and international patents and patents pending related to the
FiberChoice® brand for approximately $8 million. The
purchase, which was completed January 4, 2006, reflects CNS commitment to further
develop and grow this important brand within the companys portfolio. The purchase
was funded by CNS existing cash balances, and is expected to be earnings neutral in
the fiscal year ending March 31, 2007.

The
gross profit rate for the fiscal 2006 third quarter was 69.6 percent, down 5.7 percentage
points compared to the prior year periods gross profit rate of 75.3 percent, which
included the benefit of the European import duty refund. Advertising and promotion expense
for the 2006 third quarter of $11.4 million rose 6 percent compared to $10.7 million in
the year earlier period, primarily due to increased advertising for FiberChoice in the
U.S. and Breathe Right in several international markets.

CNS
generated $9.6 million in cash from operations through the third quarter of fiscal 2006
and ended the period with $59.7 million in cash and marketable securities. During the
first nine months of fiscal 2006, CNS repurchased 435,105 shares of its common stock for
$9.2 million.

Yesterday,
the company announced a quarterly dividend of $0.06 per share, payable on March 3, 2006 to
shareholders of record as of February 17, 2006.

Third Quarter Product
Results
        Domestic
Breathe Right sales in the 2006 third quarter were $21.5 million, down 1 percent compared
to strong prior year period sales of $21.8 million which benefited from the clear nasal
strip relaunch, including the How it Works component of our advertising
message. For the first nine months of fiscal 2006, Breathe Right domestic revenues
increased 12 percent to $54.7 million.

---

CNS, Inc. Reports Fiscal 2006 Third Quarter Results
Page 3

International
sales of Breathe Right products in the fiscal 2006 third quarter rose 35 percent to $5.3
million, up from international sales in the prior year period of $3.9 million. Sales
growth resulted from continued strong shipments to Canada, as well as normal shipments to
Japan. In the first eight months of fiscal 2005, no revenues were recorded in Japan due to
high inventory levels in that market. For the first nine months of fiscal 2006,
international sales of Breathe Right products grew 48 percent to $11.9 million.

Sales
of FiberChoice during the fiscal third quarter were $4.1 million, up 38 percent from the
prior year period sales of $3.0 million. Sales growth resulted from continued increases in
consumer demand for the expanded range of FiberChoice products. For the two FiberChoice
items launched February 2005, the assorted fruit flavored tablet has exceeded expectations
and is currently the fastest selling item in the FiberChoice product line, while the hard
candy fiber drop has fallen short of our expectations. FiberChoice also continues to
benefit from the expansion of advertising coverage to 100 percent of the United States.
For the first nine months of fiscal 2006, FiberChoice revenues increased 69 percent to
$13.8 million.

Outlook for Fiscal 2006 and Fiscal 2007
        For
the year ending March 31, 2006, CNS has updated its estimate for record sales in the range
of $109 million to $112 million, up 16 percent to 19 percent versus the 2005 fiscal year.
Sales growth in the first three quarters of fiscal 2006 rose 23 percent as the company
benefited from the launch of the two new FiberChoice products, strong consumer demand for
domestic nasal strips and the resumption of a normal shipping pattern to Japan. CNS
continues to anticipate record fully diluted earnings per share for fiscal 2006 to be in
the range of $1.05 to $1.12. This estimated range represents 19 percent to 27 percent
growth, excluding the $0.05 earnings per share benefit of the one-time duty refund
recorded in the third quarter of fiscal 2005.

For
the fiscal year ending March 31, 2007, the companys preliminary estimates for
revenue growth are in line with its long-term planning guidelines of 10 percent to 15
percent, with earnings growth expected to be slightly higher than revenue growth. The
company will provide further estimates for fiscal 2007 revenues and earnings with its
earnings release for the fourth quarter of fiscal 2006 in May.

---

CNS, Inc. Reports Fiscal 2006 Third Quarter Results
Page 4

Conference Call Webcast
        A conference call to review the third quarter results is scheduled today at 4 p.m. CT (5 p.m. ET). Interested participants
may listen to the live conference call or replay over the Internet by logging onto
CNS Web site at www.cns.com. A replay of the third quarter conference call
may also be accessed by dialing toll-free 1-800-405-2236, conference call ID 11050570,
between 6 p.m. CT on Wednesday, January 25, and 6 p.m. CT on Wednesday, February 1.

About CNS, Inc.
CNS, based in Minneapolis, designs
and markets consumer health care products, including Breathe Right®nasal
strips and FiberChoice®dietary fiber supplements. The company focuses on
products that address important consumer needs within the aging well/self-care market,
including better breathing and digestive health. Its common stock is listed on the Nasdaq
National Market under the ticker symbol CNXS. More information about CNS and
its products is available at www.cns.com.

Some of the statements contained
in this news release contain forward-looking statements that are subject to certain
business risks, including those risks described in the Companys Annual Report on
Form 10-K for the year ended March 31, 2005, as well as other filings with the Securities
and Exchange Commission. The Company undertakes no duty or obligation to update any of the
forward-looking statements after the date of this release.

---

CNS, Inc. Reports Fiscal 2006 Third Quarter Results
Page 5

CNS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts) (unaudited)

|                                      | Three Months Ended
December 31, |  | Nine Months Ended
December 31,
|------------------------------------- | ------------------------------- |  | ------------------------------
|                                      |                                 |  |                               
|
|                                      |                                 |  |                               
|Net sales                             |                                 |  | $                             
|Cost of goods sold                    |                                 |  |                               
|                                      |                                 |  |                               
|Gross profit                          |                                 |  |                               
|                                      |                                 |  |                               
|Operating expenses:                   |                                 | 
|Advertising and promotion             |                                 |  |                               
|Selling, general and administrative   |                                 |  |                               
|                                      |                                 |  |                               
|Total operating expenses              |                                 |  |                               
|                                      |                                 |  |                               
|Operating income                      |                                 |  |                               
|Investment income                     |                                 |  |                               
|                                      |                                 |  |                               
|Income before income taxes            |                                 |  |                               
|Income tax expense                    |                                 |  |                               
|                                      |                                 |  |                               
|Net income                            |                                 |  | $                             
|                                      |                                 |  |                               
|                                      |                                 |  |                               
|                                     
|Diluted net income per share          |                                 |  | $                             
|                                      |                                 |  |                               
|                                      |                                 |  |                               
|                                     
|Weighted average number of common and |                                 | 
|potential common shares outstanding   |                                 |  |                               
|                                      |                                 |  |                               
|                                      |                                 |  |                               

CNS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands) (unaudited)

|                                           | December 31,
2005 |  | March 31,
2005
|------------------------------------------ | ----------------- |  | --------------
|                                           |                   |  |               
|Current assets:                            |                   |  |               
|Cash and marketable securities             |                   |  | $             
|Accounts receivable, net                   |                   |  |               
|Inventories                                |                   |  |               
|Other current assets                       |                   |  |               
|                                           |                   |  |               
|Total current assets                       |                   |  |               
|Long-term assets                           |                   |  |               
|                                           |                   |  |               
|Total assets                               |                   |  | $             
|                                           |                   |  |               
|                                           |                   | 
|                                          
|Current liabilities                        |                   |  |               
|Stockholders equity                       |                   |  |               
|                                           |                   |  |               
|Total liabilities and stockholders equity |                   |  | $             
|                                           |                   |  |               

---

CNS, Inc. Reports Fiscal 2006 Third Quarter Results
Page 6

CNS, INC.
RECONCILIATION OF GAAP TO NON GAAP DISCLOSURES
(in thousands) (unaudited)

|                                             | Three Months Ended
December 31, |  | Nine Months Ended
December 31,
|-------------------------------------------- | ------------------------------- |  | ------------------------------
|                                             |                                 |  |                               
|
|                                             |                                 |  |                               
|Operating income, as reported                |                                 |  | $                             
|                                             |                                 |  |                               
|                                             |                                 |  |                               
|                                            
|Proforma Adjustment (1)                      |                                 |  |                               
|                                             |                                 |  |                               
|                                             |                                 |  |                               
|                                            
|Operating income, excluding favorable impact |                                 | 
|of European import duty refund               |                                 |  | $                             
|                                             |                                 |  |                               

(1)    
          The Company received a $1.1 million refund of previously paid European Community
          import duties on Breathe Right nasal strips relating to an import duty appeal.
          The Company recorded this non-recurring item as a reduction in cost of goods
          sold during the quarter ended December 31, 2004.

---